BACKGROUND: The corticotropin releasing hormone (CRH) system has been implicated in a variety of anxiety and mood-based symptoms and disorders. CRH receptor-2 (CRHR-2) plays a role in attenuating biological responses to stressful life events and trauma, making the CRHR-2 gene a strong candidate to study in relationship to PTSD. METHODS: The sample was 491 trauma-exposed white non-Hispanic veterans and their cohabitating intimate partners assessed via structured interview for lifetime DSM-IV PTSD; just over 60% met criteria for the disorder. Thirty-one single nucleotide polymorphisms (SNPs) in and near CRHR-2, obtained from an array of 2.5 million markers, were tested for association with PTSD diagnosis and symptom severity in the whole sample and in men and women separately. RESULTS: Ten SNPs showed nominally significant evidence of association with PTSD in the full sample and two SNPs (rs8192496 and rs2190242) were significant after permutation-based multiple testing correction (uncorrected ps = .0004 and .0005, odds ratios = .60 and .58, respectively). Analyses stratified by sex revealed that the effect was specific to women, who comprised 35% of the sample (uncorrected ps = .0003 and .0002, odds ratios = .41 and .35, respectively). Two additional SNPs (rs2267715 and rs2284218) also showed significant association with PTSD in women (both uncorrected ps = .001, both odds ratios = .48). CONCLUSIONS: Results suggest that CRHR-2 variants may affect risk for PTSD in women by attenuating the stress response and reducing symptoms of the disorder. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
BACKGROUND: The corticotropin releasing hormone (CRH) system has been implicated in a variety of anxiety and mood-based symptoms and disorders. CRH receptor-2 (CRHR-2) plays a role in attenuating biological responses to stressful life events and trauma, making the CRHR-2 gene a strong candidate to study in relationship to PTSD. METHODS: The sample was 491 trauma-exposed white non-Hispanic veterans and their cohabitating intimate partners assessed via structured interview for lifetime DSM-IV PTSD; just over 60% met criteria for the disorder. Thirty-one single nucleotide polymorphisms (SNPs) in and near CRHR-2, obtained from an array of 2.5 million markers, were tested for association with PTSD diagnosis and symptom severity in the whole sample and in men and women separately. RESULTS: Ten SNPs showed nominally significant evidence of association with PTSD in the full sample and two SNPs (rs8192496 and rs2190242) were significant after permutation-based multiple testing correction (uncorrected ps = .0004 and .0005, odds ratios = .60 and .58, respectively). Analyses stratified by sex revealed that the effect was specific to women, who comprised 35% of the sample (uncorrected ps = .0003 and .0002, odds ratios = .41 and .35, respectively). Two additional SNPs (rs2267715 and rs2284218) also showed significant association with PTSD in women (both uncorrected ps = .001, both odds ratios = .48). CONCLUSIONS: Results suggest that CRHR-2 variants may affect risk for PTSD in women by attenuating the stress response and reducing symptoms of the disorder. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
Entities:
Keywords:
PTSD; latent variable; rs2284218; rs8192496; single nucleotide polymorphisms; veterans; women
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Elizabeth I Flandreau; Kerry J Ressler; Michael J Owens; Charles B Nemeroff Journal: Psychoneuroendocrinology Date: 2011-05-26 Impact factor: 4.905
Authors: Rebekah G Bradley; Elisabeth B Binder; Michael P Epstein; Yilang Tang; Hemu P Nair; Wei Liu; Charles F Gillespie; Tiina Berg; Mark Evces; D Jeffrey Newport; Zachary N Stowe; Christine M Heim; Charles B Nemeroff; Ann Schwartz; Joseph F Cubells; Kerry J Ressler Journal: Arch Gen Psychiatry Date: 2008-02
Authors: Erika J Wolf; Karen S Mitchell; Mark W Logue; Clinton T Baldwin; Annemarie F Reardon; Alison Aiello; Sandro Galea; Karestan C Koenen; Monica Uddin; Derek Wildman; Mark W Miller Journal: J Trauma Stress Date: 2014-08
Authors: Karen S Mitchell; Erika J Wolf; Michelle J Bovin; Lewina O Lee; Jonathan D Green; Raymond C Rosen; Terence M Keane; Brian P Marx Journal: J Abnorm Psychol Date: 2017-02-13
Authors: Anurag Verma; Anastasia Lucas; Shefali S Verma; Yu Zhang; Navya Josyula; Anqa Khan; Dustin N Hartzel; Daniel R Lavage; Joseph Leader; Marylyn D Ritchie; Sarah A Pendergrass Journal: Am J Hum Genet Date: 2018-03-29 Impact factor: 11.025
Authors: Allison E Ashley-Koch; Melanie E Garrett; Jason Gibson; Yutao Liu; Michelle F Dennis; Nathan A Kimbrel; Jean C Beckham; Michael A Hauser Journal: J Affect Disord Date: 2015-06-12 Impact factor: 4.839
Authors: Boadie W Dunlop; Elisabeth B Binder; Dan Iosifescu; Sanjay J Mathew; Thomas C Neylan; Julius C Pape; Tania Carrillo-Roa; Charles Green; Becky Kinkead; Dimitri Grigoriadis; Barbara O Rothbaum; Charles B Nemeroff; Helen S Mayberg Journal: Biol Psychiatry Date: 2017-07-04 Impact factor: 13.382
Authors: Samantha L Connolly; Tawni B Stoop; Mark W Logue; Esther Hana Orr; Immaculata De Vivo; Mark W Miller; Erika J Wolf Journal: J Trauma Stress Date: 2018-10-19
Authors: Aditi Bhargava; Arthur P Arnold; Debra A Bangasser; Kate M Denton; Arpana Gupta; Lucinda M Hilliard Krause; Emeran A Mayer; Margaret McCarthy; Walter L Miller; Armin Raznahan; Ragini Verma Journal: Endocr Rev Date: 2021-05-25 Impact factor: 25.261